Gene · 494331
Papers1,278
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,278
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Retraction notice to "MicroRNA-382 as a tumor suppressor? Roles in tumorigenesis and clinical significance" [International Journal of Biological Macromolecules 250 (2023) 125863]. | Int J Biol Macromol | 2026 | 42586855 | PubTator, text mining | PubMed |
| MicroRNA-based diagnosis and therapy in prostate cancer. | 3 Biotech | 2026 | 42459410 | PubTator, text mining | PubMed |
| MicroRNA Regulation in Kidney Interstitial Fibrosis. | Epigenomes | 2026 | 41892370 | PubTator, text mining | PubMed |
| K48 and K63 linkage-competed ubiquitination of BECN1 promotes circPDE4D-mediated autophagy in chronic obstructive pulmonary disease. | Cell Death Dis | 2026 | 41851080 | PubTator, text mining | PubMed |
| Exosomes and Triple-Negative Breast Cancer: Current Knowledge and Clinical Significance. | Int J Mol Sci | 2026 | 41752055 | PubTator, text mining | PubMed |
| microRNA-422a promotes HIV replication and innate immune evasion by targeting MECP2. | Mol Ther Nucleic Acids | 2026 | 41717286 | PubTator, text mining | PubMed |
| Circulating microRNAs and serum proteins in breast cancer patients: Diagnostic relevance and grade-specific expression patterns. | World J Exp Med | 2025 | 41523763 | PubTator, text mining | PubMed |
| TUG1 acts as a biomarker to predict the relapse of gastric cancer after endoscopic submucosal dissection. | Arch Med Sci | 2025 | 41078943 | PubTator, text mining | PubMed |
| [Omics Study of Ovarian Malignancies: From Urine Metabolomic Profile to Minimally Invasive MicroRNA Markers]. | Mol Biol (Mosk) | 2025 | 40542633 | PubTator, text mining | PubMed |
| Transcriptomic profile induced by calcitriol in CaSki human cervical cancer cell line. | PLoS One | 2025 | 40168262 | PubTator, text mining | PubMed |
| Associations of microRNA Gene Polymorphisms With Salt Sensitivity, Longitudinal Blood Pressure Changes, and Hypertension Incidence in the Chinese Population. | J Clin Hypertens (Greenwich) | 2025 | 39994918 | PubTator, text mining | PubMed |
| Retraction notice to "miR-382 inhibits tumor progression by targeting SETD8 in non-small cell lung cancer"[Biomed. Pharmacother. 86 (2017) 248-253]. | Biomed Pharmacother | 2025 | 39863494 | PubTator, text mining | PubMed |
| miR-542-3p/PIK3R1 axis is involved in hsa_circ_0087104-mediated inhibition of esophageal squamous cell carcinoma metastasis. | Am J Cancer Res | 2024 | 39803650 | PubTator, text mining | PubMed |
| The Association Between Anti-Neoplastic Effects of Curcumin and Urogenital Cancers: A Systematic Review. | Biomed Res Int | 2024 | 39445208 | PubTator, text mining | PubMed |
| [Corrigendum] miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer. | Int J Oncol | 2024 | 39329219 | PubTator, text mining | PubMed |
| MicroRNA expression alteration in chronic thromboembolic pulmonary hypertension: A systematic review. | Pulm Circ | 2024 | 39308943 | PubTator, text mining | PubMed |
| MicroRNA-382 as a tumor suppressor during tumor progression. | Bioorg Med Chem Lett | 2024 | 39293533 | PubTator, text mining | PubMed |
| Maternal glucose levels and late pregnancy circulating extracellular vesicle and particle miRNAs in the MADRES pregnancy cohort. | Epigenetics | 2024 | 39292753 | PubTator, text mining | PubMed |
| Expression profile of messenger and micro RNAs related to the histaminergic system in patients with five subtypes of breast cancer. | Front Oncol | 2024 | 39267843 | PubTator, text mining | PubMed |
| Pulmonary miRNA expression after polytrauma depends on the surgical invasiveness and displays an anti-inflammatory pattern by the combined inhibition of C5 and CD14. | Front Immunol | 2024 | 39267761 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/494331/papers